Short Description

NGS genetic DNA test detecets for variant and mutation detection in DNAH9 gene for Primary ciliary dyskinesia, DNAH9 related

PreTest Information

Clinical History of Patient who is going for SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A3 Gene Brown-Vialetto-Van Laere syndrome 1 NGS Genetic DNA Test gene SLC52A21

Detail Description

DNA Labs India: DNAH9 Gene Primary Ciliary Dyskinesia

Primary ciliary dyskinesia (PCD) is a rare genetic disorder that affects the cilia in the respiratory system, causing chronic respiratory tract infections, sinusitis, and bronchiectasis. It is caused by mutations in genes that affect the structure and function of cilia. One of the genes associated with PCD is DNAH9.

DNAH9 Gene

The DNAH9 gene provides instructions for making a protein called dynein axonemal heavy chain 9. This protein is essential for the proper function of cilia in the respiratory tract. Mutations in the DNAH9 gene can lead to abnormal cilia function, resulting in PCD.

PCD Symptoms

The symptoms of PCD can vary from person to person, but commonly include:

• Chronic cough
• Chronic respiratory tract infections
• Recurrent sinusitis
• Ear infections
• Infertility in males

PCD is often misdiagnosed as asthma or other respiratory conditions, making accurate diagnosis crucial for proper treatment.

DNAH9 Related NGS Genetic DNA Test Cost

DNA Labs India offers a Next-Generation Sequencing (NGS) genetic DNA test for DNAH9 mutations associated with PCD. The test costs INR 20,000.

The NGS test uses advanced technology to sequence the DNA in the DNAH9 gene and identify any mutations that may be present. This information can help healthcare providers make an accurate diagnosis of PCD and develop an effective treatment plan.

Diagnosis and Treatment of PCD

Diagnosis of PCD typically involves a combination of clinical evaluation, imaging studies, and genetic testing. Treatment may include antibiotics to treat infections, airway clearance techniques, and surgery in severe cases.

Early diagnosis and treatment of PCD can improve outcomes and quality of life for individuals with the condition.

Conclusion

DNA Labs India offers a genetic DNA test for DNAH9 mutations associated with PCD. This test can aid in the accurate diagnosis and treatment of this rare genetic disorder. If you or someone you know is experiencing symptoms of PCD, speak with a healthcare provider about genetic testing and treatment options.

For more information on DNAH9 gene primary ciliary dyskinesia and genetic testing, visit DNA Labs India's website.